JUBLPHARMA vs SIGACHI: Stock Comparison

JUBILANT PHARMOVA vs SIGACHI INDUSTRIESUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

JUBILANT PHARMOVA is the larger company by market capitalisation. JUBILANT PHARMOVA shows a lower P/E, a higher ROE and a higher dividend yield, while SIGACHI INDUSTRIES shows lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

JUBLPHARMA leads 11; SIGACHI leads 2 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

JUBLPHARMASIGACHI

Valuation lens

What price are you paying?

Market CapContext only
₹14,774 Cr
₹1,327 Cr
P/E RatioJUBLPHARMA has the lower reading
40.9x
50.95x
P/B RatioJUBLPHARMA has the lower reading
2.03x
2.46x
EPSJUBLPHARMA has the higher reading
₹3.55
₹0.17
Book ValueContext only
₹445.48
₹13.84
Dividend YieldJUBLPHARMA has the higher reading
0.57%
0.31%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
JUBLPHARMA is the larger company
₹14,774 Cr vs ₹1,327 Cr
P/E Ratio
JUBLPHARMA has a lower P/E
40.9x vs 50.95x
P/B Ratio
JUBLPHARMA has a lower P/B
2.03x vs 2.46x
EPS
JUBLPHARMA has higher earnings per share
₹3.55 vs ₹0.17
Dividend Yield
JUBLPHARMA has a higher dividend yield
0.57% vs 0.31%
Revenue Growth (TTM YoY)
JUBLPHARMA has faster revenue growth
18.7% vs 16.22%
EPS Growth (TTM YoY)
SIGACHI has faster EPS growth
0% vs -22.4%
Qtr Sales Growth
JUBLPHARMA has stronger quarterly sales growth
3,222.5% vs -18.96%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJUBLPHARMASIGACHI
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricJUBLPHARMASIGACHI
Live Price₹924.5₹34.74
Day Change1.83%6.73%
Volume4.98 L92.15 L
52-Week High₹1,183₹46.73
52-Week Low₹786.05₹16.65
Distance from 52W High-21.85%-25.66%

Valuation

MetricJUBLPHARMASIGACHI
Market Cap₹14,774 Cr₹1,327 Cr
P/E Ratio40.9x50.95x
P/B Ratio2.03x2.46x
EPS₹3.55₹0.17
Book Value₹445.48₹13.84
Dividend Yield0.57%0.31%

Growth

MetricJUBLPHARMASIGACHI
Revenue Growth (TTM YoY)18.7%16.22%
EPS Growth (TTM YoY)-22.4%0%
Qtr Sales Growth3,222.5%-18.96%
Qtr Profit Growth672.6%-20.11%

Profitability & Leverage

MetricJUBLPHARMASIGACHI
ROE5.6%-16.71%
ROCE6.19%-13.23%
Net Margin5.28%-17.33%
Operating Margin9.98%-19.63%
Debt to Equity0.45x0.21x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricJUBLPHARMASIGACHI
Promoter Holding44.39%36.69%
FII Holding15.87% 0.03 pp1.25% 0.05 pp
DII Holding12.4% 0.78 pp0%
Public Holding23.5% 0.74 pp62.05% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: JUBILANT PHARMOVA and SIGACHI INDUSTRIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.